期刊文献+

载基因壳聚糖纳米粒的制备及其相关性质的研究 被引量:1

Preparation and Characteristics of Chitosan Nanoparticles Carrying Gene
下载PDF
导出
摘要 目的:制备壳聚糖栽基因纳米粒,并对其体外相关性质进行初步研究。方法:采用复凝聚法制备载基因纳米粒;用纳米粒度仪测量粒度分布,分散性和Zeta电位;用透射电镜观察粒子的形态;用紫外分光光度法和比色法测定包封率和载药量,并对主要影响因素进行考察。用凝胶阻滞分析和电性结合分析对载药方式进行初步推测。结果:所制备的载基因纳米粒形态规则,大多呈球形,纳米粒平均粒径为263.2 nm,粒径分布较窄,多分散度为0.213,Zeta电位为19.8 mV;包封率大于90%,载药量约30%;凝胶阻滞和电性结合分析结果表明,非甲基化胞嘧啶鸟嘌呤的寡核苷酸链(CPG-ODN)与壳聚糖分子间可通过电性结合作用而完全结合。结论:采用复凝聚法可制备粒度分布均匀,形态规则,具有较高包封率和载药量的载基因壳聚糖纳米粒;电性结合作用是载基因壳聚糖纳米粒载药的主要方式。 Objective: To prepare chitosan nanoparticles (CS-NP) carrying gene and study its characteristics in vitro. Method: The chitosan nanoparticles carrying gene were prepared by complex coacervation. Its size distribution , polydispersity and Zeta potential were determined by nanoparticle size analyzer; The morphology was observed by transmission electronic micrograph. The encapsulating rate and loading efficiency were determined by ultraviolet spectrophotometry and colorimetry. The manner of drug loading was speculated by Gel retardation assay and electronic-combination analysis. Result: The morphology of CS-NP was mostly spherical and well-dis- tributed. The mean diameter was about 263.2 nm with polydispersity 0. 213 and its Zeta potential was about 19.8 mV. The encapsula- ting rate was more than 90% and the loading efficiency was approximately 30%. The results of gel retardation and electronic-combination analysis showed chitosan could completely combine the CPG-ODN by electronic combination. Conclusion: The CS-NP with welldistributed spherical morphology ,high encapsulating rate and loading efficiency can be prepared by complex coacervation. Electroniccombination is the main manner for CS-NP to carry gene.
出处 《中国药师》 CAS 2008年第8期901-904,共4页 China Pharmacist
关键词 基因传递 壳聚糖 纳米粒 包封率 载药量 Gene delivery Chitosan Nanoparticle Encapsulating rate Loading efficiency
  • 相关文献

参考文献4

  • 1Alton EW, Geddes DM. Gene therapy for cystic fibrosis:a clinical perspective [J]. Gene Ther,1999 ,2 ( 2 ):88-95
  • 2Mao HQ, Roy K, Troung-Le VL, et al. Chitosan-DNA nanoparticles as gene carriers:synthesis, characterization and transfection efficiency [J]. J Control Release,2001,70(3) :399-421
  • 3黄伟,崔光华,贺俊峰,周旭,张强.壳聚糖纳米粒用作基因递送载体的初步研究[J].药学学报,2002,37(12):981-985. 被引量:28
  • 4Lee KY, Kwon IC, Kim YH, et al. Preparation of chitosan self-aggregates as a gene delivery system [J]. J Control Release, 1998,51 (2-3): 213-220

二级参考文献11

  • 1Walter E, Dreher D, Kok M, et al. Hydrophilic poly(D,L-lactide-co-glycolide) microspheres for the delivery of DNA to human-derived macrophages and dendritic celles [J]. J Controlled Release, 2001,76(1-2):149-168.
  • 2Truong-Le VL, August JT, Leong KW. Controlled gene delivery by DNA-gelatin nanospheres [J]. Hum Gene Ther, 1998,9(12):1709-1717.
  • 3Li XW, Liu JL, Wei YQ, et al. Preparation of polysaccharide nanoparticles for controlled gene release [J]. J Pharm Pharmacol, 1999,51(Supplement):176.
  • 4Hirosue S, Muller BG, Mulligan RC, et al. Pasmid DNA encapsulation and released from solvent diffusion nanospheres [J]. J Controlled Release, 2001,70(1-2):231-242.
  • 5Barman SP, Lunsford L, Chambers P, et al. Two methods for quantifying DNA extracted from poly(lactide-co-glycolide) microspheres [J]. J Controlled Release, 2000,69(3):337-344.
  • 6Crystal RG. The gene as the drug [J]. Nat Med, 1995,1(1):15-17.
  • 7Tomlinson E, Rolland AP. Controllable gene therapy: Pharmaceutics of non-viral gene delivery systems [J]. J Controlled Release, 1996,39(2-3):357-372.
  • 8Mulligan RC. The basic sciences of gene therapy [J]. Science, 1993,260(5110):926-932.
  • 9Du BH. Gene Therapy: Principle and Practice [M]. Tianjin: Tianjin Science and Technology Press, 1999.90-91.
  • 10Kikuchi H, Suzuki N, Ebihara K, et al. Gene delivery using liposome technology [J]. J Controlled Release,1999,62(1-2):269-277.

共引文献27

同被引文献30

  • 1周旭 ,全东琴 ,崔光华 ,李前 ,袁海龙 ,高春生 .丁酰胆碱酯酶基因-壳聚糖纳米粒初步研究[J].解放军药学学报,2005,21(1):20-23. 被引量:5
  • 2汤爱国,张阳德.O-羧甲基乳糖酰化壳聚糖-聚乳酸阿霉素纳米粒在大鼠体内的靶向性研究[J].中国现代医学杂志,2006,16(13):1941-1943. 被引量:7
  • 3林爱华,刘奕明,平其能.壳聚糖纳米粒表面游离氨基与纳米粒特性研究[J].药学学报,2007,42(3):323-328. 被引量:24
  • 4Chae SY,Son S,Lee M,et al. Deoxycholie acid-conjugated chi- tosan oligosaccharide nanoparticles for efficient gene carrier [J]. J Control Release, 2005,109 ( 1-3 ) : 330-344.
  • 5Sugamori T, Iwase H,Maeda M, et al. Local hemostatic effects of microcrystalline partially deacetylated chitin hydrochloride [J]. J Biomed Mater Res, 2000,49 (2) : 225 -232.
  • 6Howling GI, Detmar PW, Goddard PA, et al. The effect of chitin and chitosan on the proliferation of human skin fibroblasts and keratinocytes in vitro[J]. Biomaterials, 2001,22 (22) : 2959-2966.
  • 7Aksungur P,Sungur A,Unal S,et al. Chitosan delivery systems for the treatment of oral mucositis: in vitro and in vivo studies[J]. J Control Release, 2004,98 (2) : 269-279.
  • 8Ohya Y, Shiratani M, Kobayashi H, et al. Release behavior of 5-fluorouracil from chitosan-gel nanospheres immobilizing 5-fluo- rouracil coated with Polysaccharides and their cell specific cyto- toxicity[J]. Pure and Applied Chemistry, 1994,4 (31 ) : 629-642..
  • 9Kumbar SG,Kulkarni AR,Aminabhavi TM. Cross-linked chi- tosan microspheres for encapsulation of diclofenac sodium: effect of cross-linking agent[J]. J Microencapsu1,2002,19 (2) : 173-180.
  • 10Bodmeier R, Chen HG, Paeratakul O. A novel approach to the o- ral delivery of micro-or nano-particles [J]. Pharmaceutical Re- search, 1989,6(5) :413.

引证文献1

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部